Tuberculosis and Inequality: How Race, Caste, and Class Impact Access to Medicines 16/12/2023 Maayan Hoffman The elimination of tuberculosis cannot be achieved if medicines are locked in a “patent panoply,” according to Indian author and journalist Vidya Kishnan. Speaking to Garry Aslanyan on the most recent episode of Dialogues, a new series from the Global Health Matters podcast, the author of “Phantom Plague: How Tuberculosis Shaped History” said that “everything […] Continue reading -> A Third of People Used Antibiotics Without Prescription, WHO Europe Survey Finds 23/11/2023 Kerry Cullinan One-third of people in 14 countries in the Western Balkans, the Caucasus and Central Asia used antibiotics without a medical prescription, according to a survey released on Wednesday by the World Health Organization’s (WHO) European Region. The survey involved 8221 participants, half of whom reported taking oral antibiotics in the past 12 months. Participants came […] Continue reading -> Measles Outbreaks Surge as Millions of Children Remain Unvaccinated 17/11/2023 Stefan Anderson Measles cases and deaths have skyrocketed worldwide, with 37 countries experiencing large or disruptive outbreaks in 2022 compared to 22 in 2021, according to a joint report by the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC). The report, published on Wednesday, highlights the devastating impact of declining vaccination […] Continue reading -> Swiss, Singapore and Korean Regulatory Agencies Become First to Receive New WHO Listing 03/11/2023 Disha Shetty The drug regulatory authorities of Switzerland, the Republic of Korea and Singapore have become the first three countries to be listed as WHO-Listed Authorities (WLA) that can be used as a point of reference for other countries’ deliberations on approval of new drugs and vaccines. The WHO’s recently established WLA framework is intended to create […] Continue reading -> New Gonorrhoea Treatment Shows Positive Results in Trial Sponsored by Non-Profit Partnership 02/11/2023 Kerry Cullinan The world may soon have a new antibiotic to treat gonorrhoea after a successful phase 3 trial of an oral pill, zoliflodacin, that was led and sponsored by a non-profit organisation. The results were announced late Wednesday by the Global Antibiotic Research and Development Partnership (GARDP), which conducted the trial in collaboration with Innoviva Specialty […] Continue reading -> Nigeria Vaccinates 7.7 Million Girls Against HPV, Leading Cause of Cervical Cancer 25/10/2023 Elaine Ruth Fletcher Nigeria, Africa’s most populous country has introduced the human papillomavirus (HPV) vaccine into its routine immunization system, aiming to reach 7.7 million girls – in the continent’s largest-ever vaccination drive against the virus that causes nearly all cases of cervical cancer. Girls aged 9–14 years will receive a single dose of the vaccine, which is […] Continue reading -> BioNTech Highlights African Vaccine Partnerships – But is Challenged to Ensure Real Tech Transfer 18/10/2023 Vijay Shankar Balakrishnan BERLIN – German mRNA vaccine maker BioNTech’s partnerships with vaccine manufacturing facilities in Rwanda, Senegal and South Africa will support the African Union’s ambition to produce 60% of the continent’s vaccine needs by 2040, the company told the World Health Summit. But Ayaode Alakija, former Chief Humanitarian Coordinator for Nigeria and World Health Summit Ambassador, […] Continue reading -> Draft Pandemic Accord: IP Waivers and Benefits for Sharing Pathogen Information Are In – For Now 17/10/2023 Kerry Cullinan Time-bound waivers of intellectual property (IP) rights and benefits for countries that share information about threatening pathogens are some of the key components of the draft pandemic accord sent to World Health Organization (WHO) member states by the Intergovernmental Negotiating Body (INB) on Monday. These two issues have been major bones of contention in negotiations and […] Continue reading -> WHO Establishes Group to Advise on Medicine Pricing Policy 16/10/2023 Disha Shetty The World Health Organization (WHO) has announced a technical advisory group that will advise it on pricing policies for medicines, particularly the prices of medicines on the essential medicine list (EML).The 17-member Technical Advisory Group on Pricing Policies for Medicines (TAG-PPM) will support WHO to help strengthen policies, improve transparency about prices and improve access […] Continue reading -> Getting Global Health on the Radar of Private Sector Investors and Asset Managers 13/10/2023 Elaine Ruth Fletcher In the wake of the COVID pandemic, global health is finally getting on the radar of asset managers of large equity and investment funds – as an option for promoting social responsibility objectives among investor clientele. At a Geneva Graduate Institute session Wednesday on Investors and Civil Society Working Together, two path-finding institutions – one […] Continue reading -> Posts navigation Older postsNewer posts
A Third of People Used Antibiotics Without Prescription, WHO Europe Survey Finds 23/11/2023 Kerry Cullinan One-third of people in 14 countries in the Western Balkans, the Caucasus and Central Asia used antibiotics without a medical prescription, according to a survey released on Wednesday by the World Health Organization’s (WHO) European Region. The survey involved 8221 participants, half of whom reported taking oral antibiotics in the past 12 months. Participants came […] Continue reading -> Measles Outbreaks Surge as Millions of Children Remain Unvaccinated 17/11/2023 Stefan Anderson Measles cases and deaths have skyrocketed worldwide, with 37 countries experiencing large or disruptive outbreaks in 2022 compared to 22 in 2021, according to a joint report by the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC). The report, published on Wednesday, highlights the devastating impact of declining vaccination […] Continue reading -> Swiss, Singapore and Korean Regulatory Agencies Become First to Receive New WHO Listing 03/11/2023 Disha Shetty The drug regulatory authorities of Switzerland, the Republic of Korea and Singapore have become the first three countries to be listed as WHO-Listed Authorities (WLA) that can be used as a point of reference for other countries’ deliberations on approval of new drugs and vaccines. The WHO’s recently established WLA framework is intended to create […] Continue reading -> New Gonorrhoea Treatment Shows Positive Results in Trial Sponsored by Non-Profit Partnership 02/11/2023 Kerry Cullinan The world may soon have a new antibiotic to treat gonorrhoea after a successful phase 3 trial of an oral pill, zoliflodacin, that was led and sponsored by a non-profit organisation. The results were announced late Wednesday by the Global Antibiotic Research and Development Partnership (GARDP), which conducted the trial in collaboration with Innoviva Specialty […] Continue reading -> Nigeria Vaccinates 7.7 Million Girls Against HPV, Leading Cause of Cervical Cancer 25/10/2023 Elaine Ruth Fletcher Nigeria, Africa’s most populous country has introduced the human papillomavirus (HPV) vaccine into its routine immunization system, aiming to reach 7.7 million girls – in the continent’s largest-ever vaccination drive against the virus that causes nearly all cases of cervical cancer. Girls aged 9–14 years will receive a single dose of the vaccine, which is […] Continue reading -> BioNTech Highlights African Vaccine Partnerships – But is Challenged to Ensure Real Tech Transfer 18/10/2023 Vijay Shankar Balakrishnan BERLIN – German mRNA vaccine maker BioNTech’s partnerships with vaccine manufacturing facilities in Rwanda, Senegal and South Africa will support the African Union’s ambition to produce 60% of the continent’s vaccine needs by 2040, the company told the World Health Summit. But Ayaode Alakija, former Chief Humanitarian Coordinator for Nigeria and World Health Summit Ambassador, […] Continue reading -> Draft Pandemic Accord: IP Waivers and Benefits for Sharing Pathogen Information Are In – For Now 17/10/2023 Kerry Cullinan Time-bound waivers of intellectual property (IP) rights and benefits for countries that share information about threatening pathogens are some of the key components of the draft pandemic accord sent to World Health Organization (WHO) member states by the Intergovernmental Negotiating Body (INB) on Monday. These two issues have been major bones of contention in negotiations and […] Continue reading -> WHO Establishes Group to Advise on Medicine Pricing Policy 16/10/2023 Disha Shetty The World Health Organization (WHO) has announced a technical advisory group that will advise it on pricing policies for medicines, particularly the prices of medicines on the essential medicine list (EML).The 17-member Technical Advisory Group on Pricing Policies for Medicines (TAG-PPM) will support WHO to help strengthen policies, improve transparency about prices and improve access […] Continue reading -> Getting Global Health on the Radar of Private Sector Investors and Asset Managers 13/10/2023 Elaine Ruth Fletcher In the wake of the COVID pandemic, global health is finally getting on the radar of asset managers of large equity and investment funds – as an option for promoting social responsibility objectives among investor clientele. At a Geneva Graduate Institute session Wednesday on Investors and Civil Society Working Together, two path-finding institutions – one […] Continue reading -> Posts navigation Older postsNewer posts
Measles Outbreaks Surge as Millions of Children Remain Unvaccinated 17/11/2023 Stefan Anderson Measles cases and deaths have skyrocketed worldwide, with 37 countries experiencing large or disruptive outbreaks in 2022 compared to 22 in 2021, according to a joint report by the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC). The report, published on Wednesday, highlights the devastating impact of declining vaccination […] Continue reading -> Swiss, Singapore and Korean Regulatory Agencies Become First to Receive New WHO Listing 03/11/2023 Disha Shetty The drug regulatory authorities of Switzerland, the Republic of Korea and Singapore have become the first three countries to be listed as WHO-Listed Authorities (WLA) that can be used as a point of reference for other countries’ deliberations on approval of new drugs and vaccines. The WHO’s recently established WLA framework is intended to create […] Continue reading -> New Gonorrhoea Treatment Shows Positive Results in Trial Sponsored by Non-Profit Partnership 02/11/2023 Kerry Cullinan The world may soon have a new antibiotic to treat gonorrhoea after a successful phase 3 trial of an oral pill, zoliflodacin, that was led and sponsored by a non-profit organisation. The results were announced late Wednesday by the Global Antibiotic Research and Development Partnership (GARDP), which conducted the trial in collaboration with Innoviva Specialty […] Continue reading -> Nigeria Vaccinates 7.7 Million Girls Against HPV, Leading Cause of Cervical Cancer 25/10/2023 Elaine Ruth Fletcher Nigeria, Africa’s most populous country has introduced the human papillomavirus (HPV) vaccine into its routine immunization system, aiming to reach 7.7 million girls – in the continent’s largest-ever vaccination drive against the virus that causes nearly all cases of cervical cancer. Girls aged 9–14 years will receive a single dose of the vaccine, which is […] Continue reading -> BioNTech Highlights African Vaccine Partnerships – But is Challenged to Ensure Real Tech Transfer 18/10/2023 Vijay Shankar Balakrishnan BERLIN – German mRNA vaccine maker BioNTech’s partnerships with vaccine manufacturing facilities in Rwanda, Senegal and South Africa will support the African Union’s ambition to produce 60% of the continent’s vaccine needs by 2040, the company told the World Health Summit. But Ayaode Alakija, former Chief Humanitarian Coordinator for Nigeria and World Health Summit Ambassador, […] Continue reading -> Draft Pandemic Accord: IP Waivers and Benefits for Sharing Pathogen Information Are In – For Now 17/10/2023 Kerry Cullinan Time-bound waivers of intellectual property (IP) rights and benefits for countries that share information about threatening pathogens are some of the key components of the draft pandemic accord sent to World Health Organization (WHO) member states by the Intergovernmental Negotiating Body (INB) on Monday. These two issues have been major bones of contention in negotiations and […] Continue reading -> WHO Establishes Group to Advise on Medicine Pricing Policy 16/10/2023 Disha Shetty The World Health Organization (WHO) has announced a technical advisory group that will advise it on pricing policies for medicines, particularly the prices of medicines on the essential medicine list (EML).The 17-member Technical Advisory Group on Pricing Policies for Medicines (TAG-PPM) will support WHO to help strengthen policies, improve transparency about prices and improve access […] Continue reading -> Getting Global Health on the Radar of Private Sector Investors and Asset Managers 13/10/2023 Elaine Ruth Fletcher In the wake of the COVID pandemic, global health is finally getting on the radar of asset managers of large equity and investment funds – as an option for promoting social responsibility objectives among investor clientele. At a Geneva Graduate Institute session Wednesday on Investors and Civil Society Working Together, two path-finding institutions – one […] Continue reading -> Posts navigation Older postsNewer posts
Swiss, Singapore and Korean Regulatory Agencies Become First to Receive New WHO Listing 03/11/2023 Disha Shetty The drug regulatory authorities of Switzerland, the Republic of Korea and Singapore have become the first three countries to be listed as WHO-Listed Authorities (WLA) that can be used as a point of reference for other countries’ deliberations on approval of new drugs and vaccines. The WHO’s recently established WLA framework is intended to create […] Continue reading -> New Gonorrhoea Treatment Shows Positive Results in Trial Sponsored by Non-Profit Partnership 02/11/2023 Kerry Cullinan The world may soon have a new antibiotic to treat gonorrhoea after a successful phase 3 trial of an oral pill, zoliflodacin, that was led and sponsored by a non-profit organisation. The results were announced late Wednesday by the Global Antibiotic Research and Development Partnership (GARDP), which conducted the trial in collaboration with Innoviva Specialty […] Continue reading -> Nigeria Vaccinates 7.7 Million Girls Against HPV, Leading Cause of Cervical Cancer 25/10/2023 Elaine Ruth Fletcher Nigeria, Africa’s most populous country has introduced the human papillomavirus (HPV) vaccine into its routine immunization system, aiming to reach 7.7 million girls – in the continent’s largest-ever vaccination drive against the virus that causes nearly all cases of cervical cancer. Girls aged 9–14 years will receive a single dose of the vaccine, which is […] Continue reading -> BioNTech Highlights African Vaccine Partnerships – But is Challenged to Ensure Real Tech Transfer 18/10/2023 Vijay Shankar Balakrishnan BERLIN – German mRNA vaccine maker BioNTech’s partnerships with vaccine manufacturing facilities in Rwanda, Senegal and South Africa will support the African Union’s ambition to produce 60% of the continent’s vaccine needs by 2040, the company told the World Health Summit. But Ayaode Alakija, former Chief Humanitarian Coordinator for Nigeria and World Health Summit Ambassador, […] Continue reading -> Draft Pandemic Accord: IP Waivers and Benefits for Sharing Pathogen Information Are In – For Now 17/10/2023 Kerry Cullinan Time-bound waivers of intellectual property (IP) rights and benefits for countries that share information about threatening pathogens are some of the key components of the draft pandemic accord sent to World Health Organization (WHO) member states by the Intergovernmental Negotiating Body (INB) on Monday. These two issues have been major bones of contention in negotiations and […] Continue reading -> WHO Establishes Group to Advise on Medicine Pricing Policy 16/10/2023 Disha Shetty The World Health Organization (WHO) has announced a technical advisory group that will advise it on pricing policies for medicines, particularly the prices of medicines on the essential medicine list (EML).The 17-member Technical Advisory Group on Pricing Policies for Medicines (TAG-PPM) will support WHO to help strengthen policies, improve transparency about prices and improve access […] Continue reading -> Getting Global Health on the Radar of Private Sector Investors and Asset Managers 13/10/2023 Elaine Ruth Fletcher In the wake of the COVID pandemic, global health is finally getting on the radar of asset managers of large equity and investment funds – as an option for promoting social responsibility objectives among investor clientele. At a Geneva Graduate Institute session Wednesday on Investors and Civil Society Working Together, two path-finding institutions – one […] Continue reading -> Posts navigation Older postsNewer posts
New Gonorrhoea Treatment Shows Positive Results in Trial Sponsored by Non-Profit Partnership 02/11/2023 Kerry Cullinan The world may soon have a new antibiotic to treat gonorrhoea after a successful phase 3 trial of an oral pill, zoliflodacin, that was led and sponsored by a non-profit organisation. The results were announced late Wednesday by the Global Antibiotic Research and Development Partnership (GARDP), which conducted the trial in collaboration with Innoviva Specialty […] Continue reading -> Nigeria Vaccinates 7.7 Million Girls Against HPV, Leading Cause of Cervical Cancer 25/10/2023 Elaine Ruth Fletcher Nigeria, Africa’s most populous country has introduced the human papillomavirus (HPV) vaccine into its routine immunization system, aiming to reach 7.7 million girls – in the continent’s largest-ever vaccination drive against the virus that causes nearly all cases of cervical cancer. Girls aged 9–14 years will receive a single dose of the vaccine, which is […] Continue reading -> BioNTech Highlights African Vaccine Partnerships – But is Challenged to Ensure Real Tech Transfer 18/10/2023 Vijay Shankar Balakrishnan BERLIN – German mRNA vaccine maker BioNTech’s partnerships with vaccine manufacturing facilities in Rwanda, Senegal and South Africa will support the African Union’s ambition to produce 60% of the continent’s vaccine needs by 2040, the company told the World Health Summit. But Ayaode Alakija, former Chief Humanitarian Coordinator for Nigeria and World Health Summit Ambassador, […] Continue reading -> Draft Pandemic Accord: IP Waivers and Benefits for Sharing Pathogen Information Are In – For Now 17/10/2023 Kerry Cullinan Time-bound waivers of intellectual property (IP) rights and benefits for countries that share information about threatening pathogens are some of the key components of the draft pandemic accord sent to World Health Organization (WHO) member states by the Intergovernmental Negotiating Body (INB) on Monday. These two issues have been major bones of contention in negotiations and […] Continue reading -> WHO Establishes Group to Advise on Medicine Pricing Policy 16/10/2023 Disha Shetty The World Health Organization (WHO) has announced a technical advisory group that will advise it on pricing policies for medicines, particularly the prices of medicines on the essential medicine list (EML).The 17-member Technical Advisory Group on Pricing Policies for Medicines (TAG-PPM) will support WHO to help strengthen policies, improve transparency about prices and improve access […] Continue reading -> Getting Global Health on the Radar of Private Sector Investors and Asset Managers 13/10/2023 Elaine Ruth Fletcher In the wake of the COVID pandemic, global health is finally getting on the radar of asset managers of large equity and investment funds – as an option for promoting social responsibility objectives among investor clientele. At a Geneva Graduate Institute session Wednesday on Investors and Civil Society Working Together, two path-finding institutions – one […] Continue reading -> Posts navigation Older postsNewer posts
Nigeria Vaccinates 7.7 Million Girls Against HPV, Leading Cause of Cervical Cancer 25/10/2023 Elaine Ruth Fletcher Nigeria, Africa’s most populous country has introduced the human papillomavirus (HPV) vaccine into its routine immunization system, aiming to reach 7.7 million girls – in the continent’s largest-ever vaccination drive against the virus that causes nearly all cases of cervical cancer. Girls aged 9–14 years will receive a single dose of the vaccine, which is […] Continue reading -> BioNTech Highlights African Vaccine Partnerships – But is Challenged to Ensure Real Tech Transfer 18/10/2023 Vijay Shankar Balakrishnan BERLIN – German mRNA vaccine maker BioNTech’s partnerships with vaccine manufacturing facilities in Rwanda, Senegal and South Africa will support the African Union’s ambition to produce 60% of the continent’s vaccine needs by 2040, the company told the World Health Summit. But Ayaode Alakija, former Chief Humanitarian Coordinator for Nigeria and World Health Summit Ambassador, […] Continue reading -> Draft Pandemic Accord: IP Waivers and Benefits for Sharing Pathogen Information Are In – For Now 17/10/2023 Kerry Cullinan Time-bound waivers of intellectual property (IP) rights and benefits for countries that share information about threatening pathogens are some of the key components of the draft pandemic accord sent to World Health Organization (WHO) member states by the Intergovernmental Negotiating Body (INB) on Monday. These two issues have been major bones of contention in negotiations and […] Continue reading -> WHO Establishes Group to Advise on Medicine Pricing Policy 16/10/2023 Disha Shetty The World Health Organization (WHO) has announced a technical advisory group that will advise it on pricing policies for medicines, particularly the prices of medicines on the essential medicine list (EML).The 17-member Technical Advisory Group on Pricing Policies for Medicines (TAG-PPM) will support WHO to help strengthen policies, improve transparency about prices and improve access […] Continue reading -> Getting Global Health on the Radar of Private Sector Investors and Asset Managers 13/10/2023 Elaine Ruth Fletcher In the wake of the COVID pandemic, global health is finally getting on the radar of asset managers of large equity and investment funds – as an option for promoting social responsibility objectives among investor clientele. At a Geneva Graduate Institute session Wednesday on Investors and Civil Society Working Together, two path-finding institutions – one […] Continue reading -> Posts navigation Older postsNewer posts
BioNTech Highlights African Vaccine Partnerships – But is Challenged to Ensure Real Tech Transfer 18/10/2023 Vijay Shankar Balakrishnan BERLIN – German mRNA vaccine maker BioNTech’s partnerships with vaccine manufacturing facilities in Rwanda, Senegal and South Africa will support the African Union’s ambition to produce 60% of the continent’s vaccine needs by 2040, the company told the World Health Summit. But Ayaode Alakija, former Chief Humanitarian Coordinator for Nigeria and World Health Summit Ambassador, […] Continue reading -> Draft Pandemic Accord: IP Waivers and Benefits for Sharing Pathogen Information Are In – For Now 17/10/2023 Kerry Cullinan Time-bound waivers of intellectual property (IP) rights and benefits for countries that share information about threatening pathogens are some of the key components of the draft pandemic accord sent to World Health Organization (WHO) member states by the Intergovernmental Negotiating Body (INB) on Monday. These two issues have been major bones of contention in negotiations and […] Continue reading -> WHO Establishes Group to Advise on Medicine Pricing Policy 16/10/2023 Disha Shetty The World Health Organization (WHO) has announced a technical advisory group that will advise it on pricing policies for medicines, particularly the prices of medicines on the essential medicine list (EML).The 17-member Technical Advisory Group on Pricing Policies for Medicines (TAG-PPM) will support WHO to help strengthen policies, improve transparency about prices and improve access […] Continue reading -> Getting Global Health on the Radar of Private Sector Investors and Asset Managers 13/10/2023 Elaine Ruth Fletcher In the wake of the COVID pandemic, global health is finally getting on the radar of asset managers of large equity and investment funds – as an option for promoting social responsibility objectives among investor clientele. At a Geneva Graduate Institute session Wednesday on Investors and Civil Society Working Together, two path-finding institutions – one […] Continue reading -> Posts navigation Older postsNewer posts
Draft Pandemic Accord: IP Waivers and Benefits for Sharing Pathogen Information Are In – For Now 17/10/2023 Kerry Cullinan Time-bound waivers of intellectual property (IP) rights and benefits for countries that share information about threatening pathogens are some of the key components of the draft pandemic accord sent to World Health Organization (WHO) member states by the Intergovernmental Negotiating Body (INB) on Monday. These two issues have been major bones of contention in negotiations and […] Continue reading -> WHO Establishes Group to Advise on Medicine Pricing Policy 16/10/2023 Disha Shetty The World Health Organization (WHO) has announced a technical advisory group that will advise it on pricing policies for medicines, particularly the prices of medicines on the essential medicine list (EML).The 17-member Technical Advisory Group on Pricing Policies for Medicines (TAG-PPM) will support WHO to help strengthen policies, improve transparency about prices and improve access […] Continue reading -> Getting Global Health on the Radar of Private Sector Investors and Asset Managers 13/10/2023 Elaine Ruth Fletcher In the wake of the COVID pandemic, global health is finally getting on the radar of asset managers of large equity and investment funds – as an option for promoting social responsibility objectives among investor clientele. At a Geneva Graduate Institute session Wednesday on Investors and Civil Society Working Together, two path-finding institutions – one […] Continue reading -> Posts navigation Older postsNewer posts
WHO Establishes Group to Advise on Medicine Pricing Policy 16/10/2023 Disha Shetty The World Health Organization (WHO) has announced a technical advisory group that will advise it on pricing policies for medicines, particularly the prices of medicines on the essential medicine list (EML).The 17-member Technical Advisory Group on Pricing Policies for Medicines (TAG-PPM) will support WHO to help strengthen policies, improve transparency about prices and improve access […] Continue reading -> Getting Global Health on the Radar of Private Sector Investors and Asset Managers 13/10/2023 Elaine Ruth Fletcher In the wake of the COVID pandemic, global health is finally getting on the radar of asset managers of large equity and investment funds – as an option for promoting social responsibility objectives among investor clientele. At a Geneva Graduate Institute session Wednesday on Investors and Civil Society Working Together, two path-finding institutions – one […] Continue reading -> Posts navigation Older postsNewer posts
Getting Global Health on the Radar of Private Sector Investors and Asset Managers 13/10/2023 Elaine Ruth Fletcher In the wake of the COVID pandemic, global health is finally getting on the radar of asset managers of large equity and investment funds – as an option for promoting social responsibility objectives among investor clientele. At a Geneva Graduate Institute session Wednesday on Investors and Civil Society Working Together, two path-finding institutions – one […] Continue reading -> Posts navigation Older postsNewer posts